Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Qutenza (Topical Capsaicin 8%) in Treating Neuropathic Pain From Critical Ischaemia in Patients With End-stage Renal Failure

NCT01704339 is registered in ClinicalTrials.gov with Emma Aitken as lead sponsor.

NCT NCT01704339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01704339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Qutenza (Topical Capsaicin 8%) in Treating Neuropathic Pain From Critical Ischaemia in Patients With End-stage Renal Failure
Lead sponsor
Emma Aitken
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2012
Completion date
March 31, 2014
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal failure, neuropathic pain